Statistics for Amedisys (id:7523 AMED)
Valuation metrics
Market cap
2.95B
Enterprise value
3.22B
Trailing P/E (ttm)
35.71
Forward P/E
17.61
PEG ratio
17.61
Price/Sales (ttm)
1.27
Price/Book (mrq)
2.57
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
13.76
Overview
Shares outstanding
32.75M
Float
32.10M
Shares short
2.26M
% Held by insiders
0.02%
% Held by institutions
0.90%
Average volume (10 days)
832.82K
Average volume (90 days)
Price summary
52-Week low
88.81
52-Week high
98.95
52-Week change
-4.17%
Beta
0.78
50-Day moving average
95.73
200-Day moving average
94.84
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
June 11th, 2014
Last split factor
2:1
Last split date
December 05th, 2006
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
3.57%
Operating margin
8.00%
Operational effectiveness
Return on assets
6.27%
Return on equity
7.21%
Income statement
Revenue (ttm)
71.00
Revenue per share (ttm)
71.00
Quarterly revenue growth (yoy)
-0.35
Gross profit (ttm)
990.87M
EBITDA
286.93M
Net income to common (ttm)
82.93M
Diluted EPS (ttm)
2.52
Quarterly earnings growth (yoy)
-34.90%
Balance sheet
Total cash (mrq)
245.45M
Total cash per share (mrq)
7.49
Total debt (mrq)
467.67M
Total Debt/Equity (mrq)
38.96
Current ratio (mrq)
119.30%
Book value per share (mrq)
35.04
Cash flow
Cash flow statement
211.70M
Levered free cash flow (LFCF)
264.57M